Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest Expenses (2020 - 2025)

Historic Interest Expenses for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $4000.0.

  • RxSight's Interest Expenses fell 2000.0% to $4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year decrease of 476.19%. This contributed to the annual value of $21000.0 for FY2024, which is 9936.52% down from last year.
  • Per RxSight's latest filing, its Interest Expenses stood at $4000.0 for Q3 2025, which was down 2000.0% from $5000.0 recorded in Q2 2025.
  • RxSight's 5-year Interest Expenses high stood at $1.6 million for Q2 2023, and its period low was $4000.0 during Q4 2023.
  • In the last 5 years, RxSight's Interest Expenses had a median value of $698000.0 in 2021 and averaged $630210.5.
  • In the last 5 years, RxSight's Interest Expenses soared by 3586666.67% in 2021 and then tumbled by 9972.43% in 2023.
  • Over the past 5 years, RxSight's Interest Expenses (Quarter) stood at $1.1 million in 2021, then skyrocketed by 34.48% to $1.5 million in 2022, then plummeted by 99.72% to $4000.0 in 2023, then increased by 25.0% to $5000.0 in 2024, then dropped by 20.0% to $4000.0 in 2025.
  • Its Interest Expenses was $4000.0 in Q3 2025, compared to $5000.0 in Q2 2025 and $6000.0 in Q1 2025.